These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

483 related articles for article (PubMed ID: 2843195)

  • 21. Angiotensin II does not acutely reverse the reduction of proteinuria by long-term ACE inhibition.
    Heeg JE; de Jong PE; van der Hem GK; de Zeeuw D
    Kidney Int; 1991 Oct; 40(4):734-41. PubMed ID: 1660550
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Duration of angiotensin-converting enzyme inhibition: implications for tolerability.
    Murray NH
    Cardiology; 1991; 79 Suppl 1():22-9. PubMed ID: 1655262
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discordant effects of enalapril and lisinopril on systemic and renal hemodynamics.
    Apperloo AJ; de Zeeuw D; de Jong PE
    Clin Pharmacol Ther; 1994 Dec; 56(6 Pt 1):647-58. PubMed ID: 7995007
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Angiotensin-converting enzyme inhibitors: a comparative review.
    Raia JJ; Barone JA; Byerly WG; Lacy CR
    DICP; 1990 May; 24(5):506-25. PubMed ID: 2188439
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effects of angiotensin-converting enzyme inhibitors in hypertension].
    Rahn KH
    Z Kardiol; 1988; 77 Suppl 3():69-71. PubMed ID: 2850690
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Antihypertensive effect of enalapril and lisinopril administered in combination with nonsteroid anti-inflammatory agents].
    Savenkov MP; Ivanov SN; Brodskaia SA
    Ter Arkh; 2001; 73(9):27-31. PubMed ID: 11642076
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enalapril and lisinopril in renovascular hypertension--antihypertensive and hormonal effects of two new angiotensin-converting-enzyme (ACE) inhibitors. A preliminary report.
    Karlberg BE; Fyhrquist F; Grönhagen-Riska C; Tikkanen I; Ohman KP
    Scand J Urol Nephrol Suppl; 1984; 79():103-6. PubMed ID: 6089307
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hemodynamic responses to converting enzyme inhibition in patients with renal disease.
    August P; Cody RJ; Sealey JE; Laragh JH
    Am J Hypertens; 1989 Aug; 2(8):599-603. PubMed ID: 2550029
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Twenty-four hour blood pressure effect of once-daily lisinopril, enalapril, and placebo in patients with mild to moderate hypertension.
    Whelton A; Dunne B; Glazer N; Kostis JB; Miller WE; Rector DJ; Tresznewsky ON
    J Hum Hypertens; 1992 Aug; 6(4):325-31. PubMed ID: 1331444
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antihypertensive efficacy of lisinopril. Ambulatory blood pressure monitoring.
    Zachariah PK; Sheps SG; Schwartz GL; Schirger A; Ilstrup DM; Long CR; Carlson CA
    Am J Hypertens; 1988 Jul; 1(3 Pt 3):274S-279S. PubMed ID: 2843199
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of lisinopril monotherapy on renal hemodynamics.
    Reams GP; Bauer JH
    Am J Kidney Dis; 1988 Jun; 11(6):499-507. PubMed ID: 2837083
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enalapril and lisinopril in the treatment of mild to moderate essential hypertension.
    Espinel CH; Williams JL; Coughlin SS
    Clin Ther; 1990; 12(2):181-90. PubMed ID: 2162258
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Hypertensive patient with diabetes. "Blood pressure cosmetics" are not enough here].
    MMW Fortschr Med; 2002 Jun; 144(24):53. PubMed ID: 12138889
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparison of captopril-thiazide and enalapril-thiazide combinations in the management of mild to moderate black hypertensive patients: how important is diuretic dose and duration of action of the ACE-inhibitor?
    Skoularigis J; Strugo V; Zambakides C; Eintracht S; Reddy K; Tshele E; Smith D; Sareli P
    Int J Clin Pharmacol Ther; 1996 Jun; 34(6):263-8. PubMed ID: 8793612
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduction in left ventricular mass in patients with systemic hypertension treated with enalapril, lisinopril, or fosenopril.
    Oren S; Grossman E; Frohlich ED
    Am J Cardiol; 1996 Jan; 77(1):93-6. PubMed ID: 8540468
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Captopril to Lisinopril Conversion in Pediatric Cardiothoracic Surgery Patients Less Than 7 Years of Age (RISE-7).
    Bransetter JW; Anderson M; Zaki H; Gleason ME; Beshish AG
    Pediatr Cardiol; 2024 Feb; 45(2):394-400. PubMed ID: 38153545
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Comparison of lisinopril and captopril in treatment of severe heart failure (NYHA III-IV) in high risk patients. Preliminary results of the trial].
    Risler T; Braun U; Klärner HG; Müller-Schauenburg W; Heitkamp HC; Brilla GG; Krämer BK; Seipel L
    Z Kardiol; 1991; 80 Suppl 2():40-3. PubMed ID: 1850942
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ACE inhibition and pressor responsiveness to norepinephrine in hypertensive patients.
    Malini PL; Strocchi E; Valtancoli G; Ambrosioni E
    J Clin Pharmacol; 1990 May; 30(5):422-4. PubMed ID: 2161435
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lisinopril: a nonsulfhydryl angiotensin-converting enzyme inhibitor.
    Noble TA; Murray KM
    Clin Pharm; 1988 Sep; 7(9):659-69. PubMed ID: 2853660
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Application of ambulatory blood pressure monitoring to clinical therapeutic decisions in hypertension.
    Whelton A
    J Hypertens Suppl; 1991 Jan; 9(1):S21-5. PubMed ID: 1645768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.